Current Development of Lanthanide Complexes for Biomedical Applications

Chem Asian J. 2024 Apr 2;19(7):e202400038. doi: 10.1002/asia.202400038. Epub 2024 Feb 29.

Abstract

Luminescent molecule-based bioimaging system is widely used for precise localization and distinction of cancer/tumor cells. Luminescent lanthanide (Ln(III)) complexes offer long-lived (sub-millisecond time scale) and sharp (FWHM <10 nm) emission, arising from the forbidden 4f-4f electronic transitions. Luminescent Ln(III) complex-based bioimaging has emerged as a promising option for both in vitro and in vivo visualizations. In this mini-review, the historical development and recent significant progress of luminescent Ln(III) probes for bioapplications are introduced. The recent studies are mainly focused on three points: (i) the structural modifications of Ln(III) complexes in both macrocyclic and small ligands, (ii) the acquirement of high resolution luminescence images of cancer/tumor cells and (iii) the constructions of ratiometric biosensors. Furthermore, our recent study is explained as a new Cancer GPS (cancer grade probing for determining tumor grade through photophysical property analyses of intracellular Eu(III) complex.

Keywords: Bioimaging; Biosensing; Coordination chemistry; Lanthanide complexes; luminescence properties.

Publication types

  • Review

MeSH terms

  • Biosensing Techniques*
  • Humans
  • Lanthanoid Series Elements* / chemistry
  • Ligands
  • Luminescence
  • Neoplasms* / diagnostic imaging

Substances

  • Lanthanoid Series Elements
  • Ligands